Cholelithiasis. Cholelithiasis
Conditions
Interventions
Intervention 1: Control group-A: The participants of control group-A will be given ursodiol 600 mg per day as the standard drug, ensuring that any observed results in the treatment group are due to t
Sponsors
Muhammad Institute of Medical and Allied Sciences Multan
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Participants in the study were adults aged 18 to 50 years Both male and female Participants diagnosed with cholelithiasis
Exclusion criteria
Exclusion criteria: Individuals with major systemic diseases Individuals with prior gallbladder surgery Individuals taking gallstone medications Pregnancy ladies Lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluating changes in gallstone size. Timepoint: 3 months. Method of measurement: Ultrasound or imaging techniques. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analyzing the composition of gallstones to understand any structural changes, assessing symptoms related to gallstones such as pain, bloating, and digestive discomfort to gauge symptomatic improvement, and monitoring safety parameters like adverse events. Timepoint: 3 months. Method of measurement: By finding cholesterol, bilirubin, and calcium values in body and by liver function tests. | — |
Countries
Pakistan
Contacts
Public ContactMashhud-Ul-Hasan Abid
Muhammad Institute of Medical and Allied Sciences, Multan
Outcome results
None listed